BB Biotech is an equity fund launched and managed by Bellevue Asset Management. It invests in the public equity markets across the globe. BB Biotech primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. It employs a fundamental analysis to create its portfolio. BB Biotech began operation on November 09, 1993. It has its headquarters in Schaffhausen in Switzerland.